Türeci Ö - Search Results

1

A TCR-like CAR Promotes Sensitive Antigen Recognition and Controlled T-cell Expansion Upon mRNA Vaccination.

Birtel M, Voss RH, Reinhard K, Rengstl B, Ouchan Y, Michel K, Hayduk N, Tillmann B, Becker R, Suchan M, Theobald M, Oehm P, Türeci Ö, Sahin U. Birtel M, et al. Among authors: tureci o. Cancer Res Commun. 2022 Aug 18;2(8):827-841. doi: 10.1158/2767-9764.CRC-21-0154. eCollection 2022 Aug. Cancer Res Commun. 2022. PMID: 36923303 Free PMC article.

2

Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer.

Koslowski M, Türeci O, Bell C, Krause P, Lehr HA, Brunner J, Seitz G, Nestle FO, Huber C, Sahin U. Koslowski M, et al. Among authors: tureci o. Cancer Res. 2002 Nov 15;62(22):6750-5. Cancer Res. 2002. PMID: 12438276

3

SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicity.

Krause P, Türeci O, Micke P, Buhl R, Huber C, Sahin U. Krause P, et al. Among authors: tureci o. J Immunol Methods. 2003 Dec;283(1-2):261-7. doi: 10.1016/j.jim.2003.09.014. J Immunol Methods. 2003. PMID: 14659917

4

CrELISA: a fast and robust enzyme-linked immunosorbent assay bypassing the need for purification of recombinant protein.

Türeci O, Luxemburger U, Heinen H, Mack U, Sybrecht GW, Huber C, Sahin U. Türeci O, et al. J Immunol Methods. 2004 Jun;289(1-2):191-9. doi: 10.1016/j.jim.2004.04.020. J Immunol Methods. 2004. PMID: 15251424

5

Frequent nonrandom activation of germ-line genes in human cancer.

Koslowski M, Bell C, Seitz G, Lehr HA, Roemer K, Müntefering H, Huber C, Sahin U, Türeci O. Koslowski M, et al. Among authors: tureci o. Cancer Res. 2004 Sep 1;64(17):5988-93. doi: 10.1158/0008-5472.CAN-04-1187. Cancer Res. 2004. PMID: 15342378

6

Identification of tumor-associated autoantigens with SEREX.

Türeci O, Usener D, Schneider S, Sahin U. Türeci O, et al. Methods Mol Med. 2005;109:137-54. doi: 10.1385/1-59259-862-5:137. Methods Mol Med. 2005. PMID: 15585919

7

Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1.

Türeci O, Mack U, Luxemburger U, Heinen H, Krummenauer F, Sester M, Sester U, Sybrecht GW, Sahin U. Türeci O, et al. Cancer Lett. 2006 May 8;236(1):64-71. doi: 10.1016/j.canlet.2005.05.008. Epub 2005 Jun 29. Cancer Lett. 2006. PMID: 15992994

8

Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer.

Grunwald C, Koslowski M, Arsiray T, Dhaene K, Praet M, Victor A, Morresi-Hauf A, Lindner M, Passlick B, Lehr HA, Schäfer SC, Seitz G, Huber C, Sahin U, Türeci O. Grunwald C, et al. Among authors: tureci o. Int J Cancer. 2006 May 15;118(10):2522-8. doi: 10.1002/ijc.21669. Int J Cancer. 2006. PMID: 16353146 Free article.

9

Rapid molecular dissection of viral and bacterial immunomes.

Sahin U, Türeci O, Graf C, Meyer RG, Lennerz V, Britten CM, Dumrese C, Scandella E, Wölfel T, Ludewig B. Sahin U, et al. Among authors: tureci o. Eur J Immunol. 2006 Apr;36(4):1049-57. doi: 10.1002/eji.200535538. Eur J Immunol. 2006. PMID: 16541470 Free article.

10

ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions.

Spangenberg C, Lausch EU, Trost TM, Prawitt D, May A, Keppler R, Fees SA, Reutzel D, Bell C, Schmitt S, Schiffer IB, Weber A, Brenner W, Hermes M, Sahin U, Türeci O, Koelbl H, Hengstler JG, Zabel BU. Spangenberg C, et al. Among authors: tureci o. Cancer Res. 2006 Apr 1;66(7):3715-25. doi: 10.1158/0008-5472.CAN-05-2823. Cancer Res. 2006. PMID: 16585198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page